Home › All Companies › ZYME › Current Report

Zymeworks Inc. (ZYME) — Current Report

AI-Powered SEC Filing Analysis

← All ZYME filings
Latest Current Report Filed: 2026-01-12

Key Insights

  • Zymeworks Inc. has reported a strong cash position of approximately $270.6 million as of December 31, 2025, indicating financial stability and the potential to fund planned operations beyond 2028.
  • The company announced a $125 million share repurchase plan and expects to receive $440 million in regulatory milestone payments, further strengthening its financial outlook.
  • The board has appointed Brian Cherry as a new director, bringing additional expertise to the company's leadership team.
  • The termination of Chief Financial Officer Leone Patterson is not due to any disagreement, and Kenneth Galbraith has been appointed as interim CFO.
Sentiment: Positive Significance: 8/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-01-12. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Zymeworks Inc.

Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.